Animal models of neuropathic pain
- PMID: 20030738
- DOI: 10.1111/j.1472-8206.2009.00801.x
Animal models of neuropathic pain
Abstract
Animal models are pivotal for understanding the mechanism of neuropathic pain and development of effective therapy for its optimal management. A battery of neuropathic pain models has been developed to simulate the clinical pain conditions with diverse etiology. The present review exhaustively discusses the methodology, behavioral alterations, limitations, and advantages of about 40 different animal models of neuropathic pain along with their modifications. Development of these models has contributed immensely in understanding the chronic pain and underlying peripheral as well as central pathogenic mechanisms. Furthermore, research has resulted in the development of new therapeutic agents for neuropathic pain management, and the preclinical data obtained using these animal models have been successively translated to effective pain management in clinical setup also. As each animal model has been created with specific methodology and results tend to vary largely with the slight changes related to methodology, therefore, it is essential that data from different models should be reported and interpreted in the context of the specific pain model.
© 2009 The Authors Fundamental and Clinical Pharmacology © 2009 Société Française de Pharmacologie et de Thérapeutique.
Similar articles
-
Mechanisms of disease: mechanism-based classification of neuropathic pain-a critical analysis.Nat Clin Pract Neurol. 2006 Feb;2(2):107-15. doi: 10.1038/ncpneuro0118. Nat Clin Pract Neurol. 2006. PMID: 16932532 Review.
-
Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.Pharmacol Ther. 2009 Jul;123(1):54-79. doi: 10.1016/j.pharmthera.2009.03.018. Epub 2009 Apr 23. Pharmacol Ther. 2009. PMID: 19393690
-
Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes.J Neurosci Res. 2006 May 15;83(7):1310-22. doi: 10.1002/jnr.20821. J Neurosci Res. 2006. PMID: 16511871
-
[Neuropathic pain. Physiopathological mechanisms and therapeutic perspectives].Bull Acad Natl Med. 2008 May;192(5):921-6; discussion 926-8. Bull Acad Natl Med. 2008. PMID: 19238782 French.
-
Neuropathic pain: are we out of the woods yet?Intern Med J. 2006 Apr;36(4):251-5. doi: 10.1111/j.1445-5994.2006.01046.x. Intern Med J. 2006. PMID: 16640743 Review.
Cited by
-
The Role of Microglia in Neuroinflammation of the Spinal Cord after Peripheral Nerve Injury.Cells. 2022 Jun 30;11(13):2083. doi: 10.3390/cells11132083. Cells. 2022. PMID: 35805167 Free PMC article. Review.
-
Progress in the efficacy and mechanism of spinal cord stimulation in neuropathological pain.Ibrain. 2022 Mar 2;8(1):23-36. doi: 10.1002/ibra.12020. eCollection 2022 Spring. Ibrain. 2022. PMID: 37786421 Free PMC article. Review.
-
Rediscovery of nefopam for the treatment of neuropathic pain.Korean J Pain. 2014 Apr;27(2):103-11. doi: 10.3344/kjp.2014.27.2.103. Epub 2014 Mar 28. Korean J Pain. 2014. PMID: 24748937 Free PMC article. Review.
-
Active Nerve Regeneration with Failed Target Reinnervation Drives Persistent Neuropathic Pain.eNeuro. 2017 Feb 3;4(1):ENEURO.0008-17.2017. doi: 10.1523/ENEURO.0008-17.2017. eCollection 2017 Jan-Feb. eNeuro. 2017. PMID: 28197545 Free PMC article.
-
N-acetylcysteine downregulates phosphorylated p-38 expression but does not reverse the increased superoxide anion levels in the spinal cord of rats with neuropathic pain.Braz J Med Biol Res. 2017 Feb 16;50(2):e5801. doi: 10.1590/1414-431X20165801. Braz J Med Biol Res. 2017. PMID: 28225868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials